New bradykinin antagonists having very high potency at B1 receptors
- 30 June 1996
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 33 (1-3) , 183-185
- https://doi.org/10.1016/0162-3109(96)00100-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A new class of bradykinin antagonists containing indanylglycineImmunopharmacology, 1996
- In vivo pharmacological profile of novel, potent, stable BK antagonists at B 1 and B2 receptorsImmunopharmacology, 1996
- A new generation of bradykinin antagonistsImmunopharmacology, 1996
- Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptorsImmunopharmacology, 1996
- Design, synthesis, and in vitro activity of bis(succinimido)hexane peptide heterodimers with combined B1 and B2 antagonist activityJournal of Medicinal Chemistry, 1994
- Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the ratPain, 1993
- Receptors for bradykinin in rabbit aortaeCanadian Journal of Physiology and Pharmacology, 1977
- DL-2-Indaneglycine and DL-.beta.-trimethylsilylalanineJournal of Medicinal Chemistry, 1968
- Preparation and Resolution of Cyclopentaneglycine1The Journal of Organic Chemistry, 1965